Skip to content
Clinical Trials – home

Klaipedos universiteto ligonine VšĮ

Verified siteinfo

Lithuania Liepojos G. 41, Klaipedos M. Sav., 92288 Klaipeda, Lithuania

  • 10 trials recruiting
  • Colitis ulcerative · Psoriatic arthropathy · Arteriosclerosis
  • Adults and children

About Specializations

Klaipedos universiteto ligonine VšĮ in Klaipeda, Lithuania specialises in clinical trials of conditions such as Colitis ulcerative, Psoriatic arthropathy, Arteriosclerosis, Embolism, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

Klaipedos universiteto ligonine VšĮ is conducting research in the field of cardiovascular diseases, targeting the prevention of stroke and systemic embolism in patients with atrial fibrillation. The studies compare innovative oral anticoagulants to standard therapy to determine safety and benefit.

  • Long‑term safety profile of a novel anticoagulant compared with established treatment
  • Efficacy of asundexian in reducing stroke risk in atrial fibrillation
  • Evaluation of major bleeding outcomes using ISTH criteria

A team of 19 investigators supports these two cardiovascular trials, contributing to improved treatment options for at‑risk patients.

Digestive System Diseases

Research at the hospital also addresses digestive system diseases, with a focus on ulcerative colitis. The goal is to determine whether new therapeutic agents provide lasting remission and safety for patients.

  • Long‑term efficacy of ABT‑494 in maintaining ulcerative colitis remission
  • Safety monitoring of chronic therapy in inflammatory bowel disease
  • Impact on quality of life and disease activity scores

These two trials involve the same group of investigators, reflecting the site’s commitment to advancing care in both cardiovascular and gastrointestinal fields.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Liepojos G. 41, Klaipedos M. Sav.92288 KlaipedaLithuania
Recruiting now
10 trials
Conditions studied
37
Partner status
Verified site

More sites in KlaipedaLithuania

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

43 clinical trials

Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Long‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.

A Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Graves' disease

Recruiting

Phase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs

Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

A study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis

Investigational
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Embolism

Recruiting

Comparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery

Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Study on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis

Registered drug
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center

Psoriatic arthropathy

Not yet recruiting

A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

InvestigationalNo placebo
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Rheumatoid arthritis

Not yet recruiting

Study on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo
Countries:LithuaniaLithuania
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Dr Reddy's Laboratories Limited
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.